AQST vs. CVS
AQST (Aquestive Therapeutics, Inc.) and CVS (CVS Health Corporation) are both stocks. Both are in the Healthcare sector — AQST in Drug Manufacturers - Specialty & Generic, CVS in Healthcare Plans. Over the past 5 years, AQST returned 3.09%/yr vs 7.43%/yr for CVS. At a 0.12 correlation, their price movements are largely independent.
Performance
AQST vs. CVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AQST achieves a -22.14% return, which is significantly lower than CVS's 30.17% return.
AQST
- 1D
- 6.57%
- 1M
- 22.09%
- YTD
- -22.14%
- 6M
- -14.31%
- 1Y
- 52.89%
- 3Y*
- 40.08%
- 5Y*
- 3.09%
- 10Y*
- —
CVS
- 1D
- 0.27%
- 1M
- 8.91%
- YTD
- 30.17%
- 6M
- 32.37%
- 1Y
- 57.59%
- 3Y*
- 17.92%
- 5Y*
- 7.43%
- 10Y*
- 3.97%
AQST vs. CVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | -22.14% | 81.46% | 76.24% | 123.92% | -76.81% | -27.29% | -8.08% | -7.62% | -58.14% |
CVS CVS Health Corporation | 30.17% | 84.35% | -40.77% | -12.53% | -7.63% | 54.87% | -5.14% | 17.26% | 0.60% |
Correlation
The correlation between AQST and CVS is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2018 | 0.12 |
Fundamentals
AQST:
$616.73M
CVS:
$129.91B
AQST:
-$0.61
CVS:
$2.30
AQST:
11.37
CVS:
0.32
AQST:
$50.27M
CVS:
$407.91B
AQST:
$20.92M
CVS:
$56.59B
AQST:
-$53.08M
CVS:
$9.99B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AQST vs. CVS — Risk / Return Rank
AQST
CVS
AQST vs. CVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aquestive Therapeutics, Inc. (AQST) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AQST | CVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.23 | ||
| Sortino ratioReturn per unit of downside risk | -0.79 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.34 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 0.88 | 3.52 | -2.64 |
| Martin ratioReturn relative to average drawdown | 1.63 | 9.05 | -7.42 |
Loading charts...
Drawdowns
AQST vs. CVS - Drawdown Comparison
The maximum AQST drawdown since its inception was -96.68%, which is greater than CVS's maximum drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for AQST and CVS.
Loading charts...
Drawdown Indicators
| AQST | CVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.68% | -64.07% | -32.61% |
Max Drawdown (1Y)Largest decline over 1 year | -60.61% | -16.44% | -44.17% |
Max Drawdown (3Y)Largest decline over 3 years | -63.55% | -43.98% | -19.57% |
Max Drawdown (5Y)Largest decline over 5 years | -90.11% | -56.79% | -33.32% |
Max Drawdown (10Y)Largest decline over 10 years | — | -56.79% | — |
Current DrawdownCurrent decline from peak | -73.47% | -0.38% | -73.09% |
Average DrawdownAverage peak-to-trough decline | -76.92% | -19.53% | -57.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 32.55% | 6.38% | +26.17% |
Volatility
AQST vs. CVS - Volatility Comparison
Aquestive Therapeutics, Inc. (AQST) has a higher volatility of 13.42% compared to CVS Health Corporation (CVS) at 7.76%. This indicates that AQST's price experiences larger fluctuations and is considered to be riskier than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AQST | CVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.42% | 7.76% | +5.66% |
Volatility (6M)Calculated over the trailing 6-month period | 68.81% | 25.91% | +42.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 85.11% | 31.21% | +53.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 82.71% | 30.01% | +52.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 87.63% | 29.34% | +58.29% |
Dividends
AQST vs. CVS - Dividend Comparison
AQST has not paid dividends to shareholders, while CVS's dividend yield for the trailing twelve months is around 2.62%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CVS CVS Health Corporation | 2.62% | 3.35% | 5.93% | 3.06% | 2.36% | 1.94% | 2.93% | 2.69% | 3.05% | 2.76% | 2.15% | 1.43% |
Financials
AQST vs. CVS - Financials Comparison
This section allows you to compare key financial metrics between Aquestive Therapeutics, Inc. and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AQST vs. CVS - Profitability Comparison
AQST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 14.45M. Therefore, the gross margin over that period was 0.0%.
CVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a gross profit of 15.62B and revenue of 100.43B. Therefore, the gross margin over that period was 15.6%.
AQST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported an operating income of -4.20M and revenue of 14.45M, resulting in an operating margin of -29.1%.
CVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported an operating income of 4.68B and revenue of 100.43B, resulting in an operating margin of 4.7%.
AQST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a net income of -8.06M and revenue of 14.45M, resulting in a net margin of -55.8%.
CVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a net income of 2.94B and revenue of 100.43B, resulting in a net margin of 2.9%.
Frequently Asked Questions
AQST and CVS have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AQST has higher volatility (13.42%) compared to CVS (7.76%). In terms of maximum drawdown, AQST dropped -96.68% vs CVS's -64.07%.
CVS currently has the higher Sharpe Ratio (1.85 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AQST and CVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer